Dr Amarnath Challapilli
Consultant Clinical Oncologist
MBBS, MD(Radiotherapy), MRCP-UK, FRCR, Ph.D
I am a Consultant Clinical Oncologist specialising in the treatment of urological cancers with radiotherapy, brachytherapy and chemotherapy. I also specialise in the treatment of non-melanomatous skin cancer with radiotherapy. I previously worked as a Locum Consultant Clinical Oncologist at The Royal Marsden Hospital, and was appointed to a substantive post in University Hospitals Bristol NHS Foundation Trust in February 2014.
I undertook my medical training at Osmania Medical College, Hyderabad, India and specialised in clinical oncology (M.D. Radiotherapy) at the Postgraduate Institute of Medical Education and Research, Chandigarh, India. I have worked in the UK since 2004 as a Clinical Fellow in Bristol, Christie Hospital, Manchester and at the Hammersmith Hospital, London, during which I completed my MRCP and FRCR examinations, and obtained the Certificate of Completion of Specialist Training (CESR) in 2011.
I subsequently completed my PhD at Imperial College, London in January 2014. My research focused on the translation of novel PET tracers looking at cell proliferation, apoptosis and choline metabolism into clinical studies to look at early response assessment to treatment.
Some of the principal treatments carried out by Dr Amarnath Challapilli at Spire include:
COVID-19 testing or antibody tests are not available as a standalone service at Spire Bristol Hospital.
Royal College of Radiologists, London